- Home
- AUTL vs NMAI Comparison
AUTL vs NMAI Comparison
Compare AUTL & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- NMAI
- Stock Information
- Founded
- AUTL 2014
- NMAI 2021
- Country
- AUTL United Kingdom
- NMAI United States
- Employees
- AUTL N/A
- NMAI N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- NMAI Investment Managers
- Sector
- AUTL Health Care
- NMAI Finance
- Exchange
- AUTL Nasdaq
- NMAI Nasdaq
- Market Cap
- AUTL 359.3M
- NMAI 382.1M
- IPO Year
- AUTL 2018
- NMAI N/A
- Fundamental
- Price
- AUTL $1.27
- NMAI $12.30
- Analyst Decision
- AUTL Strong Buy
- NMAI
- Analyst Count
- AUTL 5
- NMAI 0
- Target Price
- AUTL $9.32
- NMAI N/A
- AVG Volume (30 Days)
- AUTL 2.4M
- NMAI 74.8K
- Earning Date
- AUTL 05-08-2025
- NMAI 01-01-0001
- Dividend Yield
- AUTL N/A
- NMAI 13.14%
- EPS Growth
- AUTL N/A
- NMAI N/A
- EPS
- AUTL N/A
- NMAI 0.64
- Revenue
- AUTL $9,011,000.00
- NMAI N/A
- Revenue This Year
- AUTL $277.74
- NMAI N/A
- Revenue Next Year
- AUTL $221.89
- NMAI N/A
- P/E Ratio
- AUTL N/A
- NMAI $19.03
- Revenue Growth
- AUTL N/A
- NMAI N/A
- 52 Week Low
- AUTL $1.11
- NMAI $10.60
- 52 Week High
- AUTL $5.00
- NMAI $12.55
- Technical
- Relative Strength Index (RSI)
- AUTL 43.50
- NMAI 66.20
- Support Level
- AUTL $1.15
- NMAI $11.98
- Resistance Level
- AUTL $1.44
- NMAI $12.19
- Average True Range (ATR)
- AUTL 0.13
- NMAI 0.14
- MACD
- AUTL 0.01
- NMAI 0.05
- Stochastic Oscillator
- AUTL 29.27
- NMAI 94.13
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.